Joel F. Sussman insider trades
Open-market stock purchases and sales by Joel F. Sussman, Chief Accounting Officer at Galera Therapeutics, Inc, from SEC Form 4 filings since Jan 31, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- GRTX Galera Therapeutics, Inc: 2 sales, last May 1, 2025